GlassScriptPhysician profile
Cory Adam Waldman
NPI 1740445774
$5,218.33
in general payments reported to CMS, 2019-2025
39 companies · $1,049 in 2025
The $1,049 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $783 · 2020: $277 · 2021: $775 · 2022: $421 · 2023: $898 · 2024: $1,015 · 2025: $1,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,961.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $980.68 | 2019-2025 | Repatha, Repatha, Otezla |
| Abbvie INC. | $864.74 | 2019-2025 | Ubrelvy, Vraylar, Synthroid |
| Novartis Pharmaceuticals Corporation | $481.17 | 2021-2025 | |
| Pfizer INC. | $412.17 | 2021-2025 | |
| Lilly USA, LLC | $360.92 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $222.16 | 2021-2025 | Wegovy, Ozempic, Saxenda |
| Almatica Pharma LLC | $172.22 | 2021-2024 | Loreev Xr |
| Edwards Lifesciences Corporation | $165.11 | 2022-2025 | Sapien 3 Ultra Resilia, Evoque |
| Biohaven Pharmaceuticals, INC. | $162.89 | 2021 | |
| Exact Sciences Corporation | $142.55 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $104.23 | 2022-2025 | Relistor, Xifaxan |
| Kowa Pharmaceuticals America, INC. | $96.73 | 2019-2023 | Livalo, Seglentis |
| Heartflow, INC. | $90.19 | 2023-2025 | Ffrct |
| Amarin Pharma, INC. | $82.52 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $75.86 | 2022-2025 | Quviviq, Quviviq |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Waldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.